3D Cell Culture Market

3D Cell Culture Market by Product (Hydrogels, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Tissue Engineering), End User (Pharma, Biotech, Research), Region - Global Forecast to 2028

Report Code: BT 4414 Jul, 2023, by marketsandmarkets.com

The global 3D cell culture market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $2.5 billion by 2028, growing at a CAGR of 14.6% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Rising incidence of chronic diseases, increasing demand for 3D cell culture due to increased demand for personalized medicine, strong emphasis on launch of novel products by key market players is driving the market growth.

Attractive Opportunities in the 3D cell culture market

3D Cell Culture Market

To know about the assumptions considered for the study, Request for Free Sample Report

3D Cell Culture Market

3D Cell Culture Market Dynamics

DRIVER: High focus on developing alternatives to animal testing

Animal studies are widely used in pharma and scientific research to investigate complex biological phenomena that cannot be studied with a simple two-dimensional (2D) cell culture. However, there has been a growing concern over the ethical and scientific limitations of relying solely on animal models for drug testing and toxicity screening. Additionally, animal testing is costly, time-consuming, and to a certain extent, may not accurately reflect human physiological responses. Due to the mentioned factors, pharmaceutical companies and research scientists are moving towards the adoption of alternatives to animal testing, such as 3D cell culture. 3D cell culture models provide a more human-relevant and predictive platform for studying drug efficacy and toxicity, reducing the reliance on animal models. These models offer a closer representation of human tissues and organs, allowing researchers to study the effects of drugs and potential toxicities in a more physiologically relevant environment.

Regulatory bodies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have encouraged the development and adoption of 3D cell culture globally for drug screening and safety assessment. For instance, in the FDA’s Predictive Toxicology Roadmap, the government promotes the use of advanced in vitro models, including 3D cell cultures, to improve the accuracy and efficiency of toxicity testing. The increasing regulatory scrutiny and the reduction of animal testing have spurred the adoption of 3D cell culture models across various industries, including pharmaceuticals, biotechnology, cosmetics, and chemicals. Increased investment by researchers and industry players in the development and optimization of 3D cell culture technologies to create more reliable and robust alternatives to animal testing drives the growth of the 3D cell culture industry.

RESTRAINT: High costs of implementing 3D cell culture technologies

The use of 3D cell culture is increasing rapidly owing to various factors such as advantages over 2D cell culture and a ban on animal testing in several countries, among others. However, the high cost of 3D cell culture is a major challenge to the growth of the market. The cost of implementing 3D cell culture technologies can vary depending on various factors, such as the complexity of the system, the scale of production, and the specific requirements of the application. The 3D cell culture laboratory includes various instruments and consumables used for the development of 3D cell models, such as CO2 incubators, bioreactors, microfluidic devices, and specialized imaging systems. The cost of these instruments can range from a few thousand dollars to several hundred thousand dollars, depending on the complexity and functionality required. For example, a basic CO2 incubator can cost around USD 2,000, whereas bioreactors can range from USD 10,000 to more than USD 100,000. The cost of cell culture depends on the cell source and maintenance requirements. Cell lines obtained from commercial repositories can range from a few USD 100 to more than USD 1000 per vial, depending on their characteristics and usage restrictions. Primary cells, on the other hand, can be more expensive owing to complexities in isolation and characterization. Additionally, the cost of maintaining cell cultures, including media changes, passage, and cryopreservation, is considered while calculating the overall cost of 3D cell culture models.

As a result of the high cost, 3D cell culture is adopted in large research institutions and pharmaceutical companies. This can limit the access that smaller research groups and individual researchers have to this technology. The high cost of 3D cell culture is a major barrier to the adoption of this technology by a wider range of users. As technology continues to develop and the cost of 3D cell culture decreases, it is likely that this technology will become more widely available to researchers and clinicians. The high cost of 3D cell culture is likely to hamper the market growth.  

OPPORTUNITY: Emergence of microfluidics-based 3D cell culture

Microfluidic-based cell culture is a type of cell culture that uses microfluidic devices to culture cells. These devices are small and miniaturized that can be used to control the flow of fluids, making them ideal for cell culture as they can be used to create controlled microenvironments for cells..

The advantages of microfluidic-based 3D cell culture has resulted in increased adoption across the globe. Researchers and pharmaceutical companies are using this platform to develop more accurate and reliable models for drug screening and toxicity testing. Microfluidic devices allows the integration of multiple cell types, creating complex cellular microenvironments that closely mimic in vivo conditions. This helps the study of cell-cell interactions, cell migration, and tissue development, leading to better insights into disease mechanisms and drug responses. Furthermore, the ability to generate organ-on-chip models, where different organs or tissues are connected in a microfluidic system, has obtained significant consideration. Organ-on-chip technology is likely to replace animal models for drug testing, as the technology offers a more realistic representation of human physiology and can be tailored to specific diseases or patient populations.

Key players operating in have adopted various organic and inorganic strategies in order to retain their market position. The companies have adopted statergies such as partnerships, collabrations with various research institutions. For instance, In July 2021, MIMETAS and Roche collaborated to develop human disease models to characterize novel compounds in inflammatory bowel disease (IBD) and hepatitis B virus infections (HBV). The adoption of microfluidic-based cell culture is anticipated to create lucrative growth opportunities in the market.

CHALLENGE: Lack of consistency and standardization in 3D cell culture products

There has been increased adoption of 3D cell culture products in research. However, lack of consistency in 3D cell culture products is one of the major challenge expected to hinder market growth. The various factors such as standardization challenges, variability in cell culture, quality control issues, scale up and manufacturing issues might hamper the market growth. With increasing demand for 3D cell culture products, there is a need for scalable manufacturing processes. However, transitioning from small-scale research laboratory production to large-scale manufacturing can introduce additional variables that may impact the consistency of the final product. Maintaining consistent conditions, reproducible results, and batch-to-batch consistency becomes more challenging as the scale increases. Furthermore, lack of standardized protocols and guidelines for producing and characterizing 3D cell culture model is likely to further hamper the market growth in coming years.

Apart from this, cell grown on low factor scaffolds are not approved for human application. This referes to the need of materials offering functionality of ECM and specificity in biological and material properties. However, synthetic marterilas is likely to address the challenges in coming years. Lack of inconsistency in the 3D cell culture products and regulations might hamper the market growth during the forecast period.

3D cell Culture Market Ecosystem

3D Cell Culture Market Ecosystem

The scaffold-based 3D cell culture segment dominated the 3D cell culture industry 2022.

Based on product, the global 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures segments. The scaffold-based 3D cell culture segment held the largest share in the overall market in 2022. The advantages of scaffolds in 3D cell cultures, such as structural rigidity, the availability of attachment points, and support, have greatly driven the preference for scaffold-based 3D cell cultures among end users and have ensured a large share of this segment.

Pharmaceutical & Biotechnology Companies segment dominated 3D cell culture industry in 2022

Based on end users, the 3D cell culture market is segmented into pharmaceutical & biotechnology companies, research institutes, cosmetics industry, and other end users. The pharmaceutical & biotechnology companies segment held the largest share in the market in 2022. Ban on animal testing, increased investment in R&D, and the rising adoption of personalized medicines are some of the key factors likely to have a positive impact on the market growth.

North America dominated the 3D cell culture industry in 2022.

3D Cell Culture Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The global 3D cell culture market is segmented into five major regions—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America held the largest share of in  the global market. The 3D cell culture industry in North America, especially in the US, benefits from its position as a prominent center for advanced R&D in biotechnology and pharmaceuticals. The region hosts a substantial number of academic institutions, research organizations, and biotech companies that are actively involved in exploring and advancing 3D cell culture techniques. The emphasis on creating groundbreaking cell culture models and methodologies is expected to be a significant driving force behind the market’s growth in the region.

In Europe, the adoption of 3D cell culture products is high in major end-user segments such as pharmaceutical & biotechnology companies and research institutes. Though this trend is expected to continue in the coming years, the adoption of these products is expected to be higher in the European market owing to the growth of the pharmaceutical & biotechnology industries, recent commercialization of microfluidic-based products, the increasing presence of major market players, and many research activities in the region.

Key players in the 3D cell culture market include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), Avantor Inc. (US), and others.

Scope of the 3D Cell Culture Industry

Report Metric 

Details 

Market Revenue in 2023

$1.3 billion

Projected Revenue by 2028

$2.5 billion

Revenue Rate

Poised to Grow at a CAGR of 14.6%

Market Driver

High focus on developing alternatives to animal testing

Market Opportunity

Emergence of microfluidics-based 3D cell culture

This report categorizes the 3D cell culture market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Scaffold-based 3D Cell Cultures
  • Scaffold-free 3D Cell Cultures
  • Microfluidics-based 3D Cell Cultures
  • Magnetic & Bioprinted 3D Cell Cultures

By Application

  • Cancer & Stem Cell Research
  • Drug Discovery & Toxicology Testing
  • Tissue Engineering & Regenerative Medicine

By End user

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Cosmetics Industry
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Recent Developments of 3D Cell Culture Industry

  • In October 2022, Corning launched the Elplasia 12K flask featuring a unique microcavity geometry that enables easy spheroid formation, culture, treatment, assessment, and harvest, with approximately 12,000 spheroids of uniform size and shape per flask, generating 125 times more yield than conventional 96-well spheroid plates.
  • In March 2021, Thermo Fisher Scientific launched a plasma-like medium, a cell culture medium that mimics the metabolic profile of human plasma, designed to provide researchers with a realistic view of cell growth within the human body.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 30)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 RESEARCH LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
    1.8 IMPACT OF ECONOMIC RECESSION ON MARKET 
 
2 RESEARCH METHODOLOGY (Page No. - 34)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 3D CELL CULTURE MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 3 3D CELL CULTURE INDUSTRY SIZE ESTIMATION (SUPPLY SIDE ANALYSIS), 2022
          FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
          FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
           2.2.1 INSIGHTS FROM PRIMARIES
                    FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
           2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER)
                    FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 GROWTH RATE ASSUMPTIONS 
          FIGURE 8 MARKET: CAGR PROJECTIONS, 2023–2028
          FIGURE 9 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 IMPACT OF ECONOMIC RECESSION ON MARKET 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 11 MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 3D CELL CULTURE INDUSTRY, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 GEOGRAPHICAL SNAPSHOT OF 3D CELL CULTURE INDUSTRY
 
4 PREMIUM INSIGHTS (Page No. - 49)
    4.1 3D CELL CULTURE MARKET OVERVIEW 
          FIGURE 15 INCREASED FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING TO PROPEL MARKET
    4.2 NORTH AMERICA: 3D CELL CULTURE INDUSTRY, BY PRODUCT AND COUNTRY (2022) 
          FIGURE 16 SCAFFOLD-BASED 3D CELL CULTURES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.3 MARKET SHARE, BY APPLICATION, 2023 VS. 2028 
          FIGURE 17 CANCER & STEM CELL RESEARCH TO DOMINATE MARKET IN 2028
    4.4 MARKET SHARE, BY END USER, 2022 (USD MILLION) 
          FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES DOMINATED MARKET IN 2022
    4.5 MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 
          FIGURE 19 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2023 TO 2028
 
5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 20 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 4 3D CELL CULTURE INDUSTRY: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 High focus on developing alternatives to animal testing
                    5.2.1.2 Greater adoption of personalized medicine globally for multiple diseases
                    5.2.1.3 Increased government support and funding for 3D cell culture
                    5.2.1.4 Increased industry-academia collaboration on 3D cell culture and research
           5.2.2 RESTRAINTS
                    5.2.2.1 High costs of implementing 3D cell culture technologies
                    5.2.2.2 Lack of widely accepted or single standardization in 3D cell culture
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emergence of microfluidics-based 3D cell culture
                    5.2.3.2 High growth opportunities and booming biopharmaceutical sector in emerging economies
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of consistency in 3D cell culture products
                    5.2.4.2 High dependence on plastic waste disposals and consumables
                                TABLE 5 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
    5.3 RANGES/SCENARIOS 
          FIGURE 21 SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF MARKET
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 22 VALUE CHAIN ANALYSIS OF MARKET: RAW MATERIAL AND MANUFACTURING PHASE ADD MAXIMUM VALUE
    5.6 SUPPLY CHAIN ANALYSIS 
          FIGURE 23 MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM ANALYSIS 
          FIGURE 24 ECOSYSTEM ANALYSIS: MARKET
          TABLE 6 MARKET: ROLE IN ECOSYSTEM
    5.8 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 7 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.8.1 THREAT OF NEW ENTRANTS
           5.8.2 THREAT OF SUBSTITUTES
           5.8.3 BARGAINING POWER OF SUPPLIERS
           5.8.4 BARGAINING POWER OF BUYERS
           5.8.5 INTENSITY OF COMPETITIVE RIVALRY
    5.9 PATENT ANALYSIS 
           5.9.1 LIST OF MAJOR PATENTS
    5.10 PRICING ANALYSIS 
           TABLE 8 SELLING PRICE OF 3D CELL CULTURE PRODUCTS BY TOP PLAYERS (2022)
           TABLE 9 AVERAGE SELLING PRICE, BY APPLICATION (2022)
    5.11 TECHNOLOGY ANALYSIS 
           TABLE 10 ADVANTAGES AND DISADVANTAGES OF 3D CELL CULTURE TECHNIQUES
    5.12 REGULATORY ANALYSIS 
           5.12.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 14 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.13 KEY CONFERENCES AND EVENTS IN 2023 
           TABLE 15 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF 3D CELL CULTURE PRODUCTS
           5.14.2 BUYING CRITERIA
                     FIGURE 26 KEY BUYING CRITERIA FOR END USERS
 
6 3D CELL CULTURE MARKET, BY PRODUCT (Page No. - 77)
    6.1 INTRODUCTION 
          TABLE 16 3D CELL CULTURE INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 SCAFFOLD-BASED 3D CELL CULTURES 
          TABLE 17 MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 18 MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 19 NORTH AMERICA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 20 EUROPE: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 21 ASIA PACIFIC: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 HYDROGELS/ECM ANALOGS
                    6.2.1.1 Hydrogels/ECM analogs to dominate scaffold-based 3D cell cultures market during forecast period
                                TABLE 22 HYDROGELS/ECM ANALOGS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 23 NORTH AMERICA: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 24 EUROPE: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 25 ASIA PACIFIC: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 NATURAL & SYNTHETIC HYDROGELS
                    6.2.2.1 Easy synthetization on large scale and improved control of matrix architecture to propel segment
                                TABLE 26 HYDROGELS/ECM ANALOGS MARKET, BY TYPE, 2021–2028 (USD MILLION)
           6.2.3 SOLID SCAFFOLDS
                    6.2.3.1 Solid scaffolds to be widely adopted in regenerative medicine and preclinical in-vitro testing
                                TABLE 27 SOLID SCAFFOLDS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 28 NORTH AMERICA: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 29 EUROPE: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 30 ASIA PACIFIC: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.4 MICROPATTERNED SURFACES
                    6.2.4.1 Micropatterned surfaces to enhance expression of enzyme levels and drug reactivity
                                TABLE 31 MICROPATTERNED SURFACES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 32 NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 33 EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 34 ASIA PACIFIC: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 SCAFFOLD-FREE 3D CELL CULTURES 
          TABLE 35 MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 36 MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 37 NORTH AMERICA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 38 EUROPE: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 39 ASIA PACIFIC: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 LOW ATTACHMENT PLATES
                    6.3.1.1 Low attachment plates to grow at highest rate in scaffold-free 3D cell cultures market
                                TABLE 40 LOW ATTACHMENT PLATES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 41 NORTH AMERICA: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 42 EUROPE: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 43 ASIA PACIFIC: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 HANGING DROP PLATES
                    6.3.2.1 Hanging drop plates to be mostly used in stem cell differentiation and cytotoxicity research
                                TABLE 44 HANGING DROP PLATES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 45 NORTH AMERICA: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 46 EUROPE: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 47 ASIA PACIFIC: HANGING DROP PLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 3D BIOREACTORS
                    6.3.3.1 3D bioreactors to be commonly used in mass production of cells
                                TABLE 48 3D BIOREACTORS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 49 NORTH AMERICA: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 50 EUROPE: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 51 ASIA PACIFIC: 3D BIOREACTORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.4 3D PETRI DISHES
                    6.3.4.1 Europe to witness highest growth in 3D Petri dishes during study period
                                TABLE 52 3D PETRI DISHES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 53 NORTH AMERICA: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 54 EUROPE: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 55 ASIA PACIFIC: 3D PETRI DISHES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 MICROFLUIDICS-BASED 3D CELL CULTURES 
           6.4.1 MICROFLUIDICS-BASED 3D CELL CULTURES TO GROW AT HIGHEST RATE DURING FORECAST PERIOD
                    TABLE 56 MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 57 NORTH AMERICA: MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 58 EUROPE: MARKET FOR MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 59 ASIA PACIFIC: MARKET FOR 3D MICROFLUIDICS-BASED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
    6.5 MAGNETIC & BIOPRINTED 3D CELL CULTURES 
           6.5.1 3D CELL CULTURE TO BE FORMED WITHOUT MEDIA IN MAGNETIC LEVITATION
                    TABLE 60 MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 61 NORTH AMERICA: MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 62 EUROPE: MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 63 ASIA PACIFIC: MARKET FOR MAGNETIC & BIOPRINTED 3D CELL CULTURES, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 3D CELL CULTURE MARKET, BY END USER (Page No. - 104)
    7.1 INTRODUCTION 
          TABLE 64 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    7.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
           7.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE LARGEST END USERS OF 3D CELL CULTURE PRODUCTS
                    TABLE 65 MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 66 NORTH AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 67 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 68 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 RESEARCH INSTITUTES 
           7.3.1 INCREASED GOVERNMENT FUNDING FOR RESEARCH AND HIGH PREVALENCE OF CANCER TO AUGMENT MARKET
                    TABLE 69 MARKET FOR RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 70 NORTH AMERICA: MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 71 EUROPE: MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 72 ASIA PACIFIC: MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 COSMETICS INDUSTRY 
           7.4.1 FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING TO FUEL MARKET
                    TABLE 73 MARKET FOR COSMETICS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 74 NORTH AMERICA: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 75 EUROPE: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 76 ASIA PACIFIC: MARKET FOR COSMETICS INDUSTRY, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 OTHER END USERS 
          TABLE 77 MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 78 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 79 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 80 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 3D CELL CULTURE MARKET, BY APPLICATION (Page No. - 115)
    8.1 INTRODUCTION 
          TABLE 81 MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    8.2 CANCER & STEM CELL RESEARCH 
           8.2.1 RISING PREVALENCE OF CANCER AND OTHER COMPLEX DISEASES GLOBALLY TO PROPEL MARKET
                    TABLE 82 MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 83 NORTH AMERICA: MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 84 EUROPE: MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 85 ASIA PACIFIC: MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 DRUG DISCOVERY & TOXICOLOGY TESTING 
           8.3.1 INCREASED ADOPTION OF PERSONALIZED MEDICINES AND EXPANSION OF PHARMACEUTICAL COMPANIES TO SUPPORT MARKET
                    TABLE 86 MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 87 NORTH AMERICA: MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 88 EUROPE: MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 89 ASIA PACIFIC: MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE 
           8.4.1 INCREASING RESEARCH ON 3D CULTURE TECHNIQUES TO AID MARKET
                    TABLE 90 MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 91 NORTH AMERICA: MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 92 EUROPE: MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 93 ASIA PACIFIC: MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 3D CELL CULTURE MARKET, BY REGION (Page No. - 124)
    9.1 INTRODUCTION 
          TABLE 94 3D CELL CULTURE INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 27 NORTH AMERICA: MARKET SNAPSHOT
          TABLE 95 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 96 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 97 NORTH AMERICA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 98 NORTH AMERICA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 99 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
          TABLE 100 NORTH AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Adoption of innovative techniques and government-funded initiatives to drive market
                                TABLE 101 US: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 102 US: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 103 US: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 104 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 105 US: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Advancements in regenerative medicine to boost market
                                TABLE 106 CANADA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 107 CANADA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 108 CANADA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 109 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 110 CANADA: 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.2.3 NORTH AMERICA: RECESSION IMPACT
    9.3 EUROPE 
          TABLE 111 EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 112 EUROPE: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 113 EUROPE: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 114 EUROPE: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 115 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
          TABLE 116 EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Spike in investments by key players and growing funding from government organizations to fuel market
                                TABLE 117 GERMANY: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 118 GERMANY: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 119 GERMANY: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 120 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 121 GERMANY: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Growth in life sciences industry to drive market
                                TABLE 122 UK: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 123 UK: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 124 UK: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 125 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 126 UK: 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Growth in biotechnology industry to propel market
                                TABLE 127 FRANCE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 128 FRANCE: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 129 FRANCE: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 130 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 131 FRANCE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Increase in research activities and funds to boost market
                                TABLE 132 ITALY: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 133 ITALY: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 134 ITALY: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 135 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 136 ITALY: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Increased collaborations in research and focus on personalized medicine to drive market
                                TABLE 137 SPAIN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 138 SPAIN: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 139 SPAIN: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 140 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 141 SPAIN: 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 142 REST OF EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 143 REST OF EUROPE: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 144 REST OF EUROPE: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 145 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 146 REST OF EUROPE: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.3.7 EUROPE: RECESSION IMPACT
    9.4 ASIA PACIFIC 
          FIGURE 28 ASIA PACIFIC: MARKET SNAPSHOT
          TABLE 147 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 148 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
          TABLE 149 ASIA PACIFIC: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 150 ASIA PACIFIC: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 151 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
          TABLE 152 ASIA PACIFIC: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.1 CHINA
                    9.4.1.1 Government support and strategic initiatives by key players to strengthen use of biotechnology
                                TABLE 153 CHINA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 154 CHINA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 155 CHINA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 156 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 157 CHINA: 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
           9.4.2 JAPAN
                    9.4.2.1 Rising prevalence of cancer and increased adoption of 3D cell culture to augment market growth
                                TABLE 158 JAPAN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 159 JAPAN: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 160 JAPAN: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 161 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 162 JAPAN: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Growth in life sciences industry to support market
                                TABLE 163 INDIA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 164 INDIA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 165 INDIA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 166 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 167 INDIA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.4.4 REST OF ASIA PACIFIC
                    TABLE 168 REST OF ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
           9.4.5 ASIA PACIFIC: RECESSION IMPACT
                    TABLE 169 REST OF ASIA PACIFIC: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 170 REST OF ASIA PACIFIC: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 171 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 172 REST OF ASIA PACIFIC: 3D CELL CULTURE INDUSTRY, BY END USER, 2021–2028 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 GROWING GOVERNMENT INVESTMENTS AND AVAILABILITY OF GRANTS FOR CELL-BASED RESEARCH TO DRIVE MARKET
                    TABLE 173 LATIN AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 174 LATIN AMERICA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 175 LATIN AMERICA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 176 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 177 LATIN AMERICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.5.2 LATIN AMERICA: RECESSION IMPACT
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 INCREASED FUNDING INITIATIVES AND STRATEGIC PARTNERSHIPS IN RESEARCH TO AID MARKET
                    TABLE 178 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 179 MIDDLE EAST & AFRICA: MARKET FOR SCAFFOLD-BASED 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 180 MIDDLE EAST & AFRICA: MARKET FOR SCAFFOLD-FREE 3D CELL CULTURES, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 181 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                    TABLE 182 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2021–2028 (USD MILLION)
           9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
 
10 COMPETITIVE LANDSCAPE (Page No. - 180)
     10.1 INTRODUCTION 
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             FIGURE 29 3D CELL CULTURE MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
     10.3 REVENUE SHARE ANALYSIS 
             FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
     10.4 MARKET SHARE ANALYSIS 
             FIGURE 31 MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
             TABLE 183 MARKET: DEGREE OF COMPETITION
     10.5 COMPANY EVALUATION QUADRANT 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 32 MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
     10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             10.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 184 MARKET: COMPANY PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
             10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
                        TABLE 185 MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
     10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 
             10.7.1 PROGRESSIVE COMPANIES
             10.7.2 STARTING BLOCKS
             10.7.3 RESPONSIVE COMPANIES
             10.7.4 DYNAMIC COMPANIES
                        FIGURE 33 MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
     10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 
             TABLE 186 MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
             TABLE 187 MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SME PLAYERS
     10.9 COMPETITIVE SCENARIOS AND TRENDS 
             10.9.1 PRODUCT LAUNCHES
                        TABLE 188 MARKET: PRODUCT LAUNCHES, JANUARY 2020–APRIL 2023
             10.9.2 DEALS
                        TABLE 189 MARKET: DEALS, JANUARY 2020–APRIL 2023
             10.9.3 OTHER DEVELOPMENTS
                        TABLE 190 3D CELL CULTURE MARKET: OTHER DEVELOPMENTS, JANUARY 2020–APRIL 2023
 
11 COMPANY PROFILES (Page No. - 195)
     11.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             11.1.1 THERMO FISHER SCIENTIFIC, INC.
                        TABLE 191 THERMO FISHER SCIENTIFIC, INC.: COMPANY OVERVIEW
                        FIGURE 34 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2022)
             11.1.2 MERCK KGAA
                        TABLE 192 MERCK KGAA: COMPANY OVERVIEW
                        FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022)
             11.1.3 CORNING INCORPORATED
                        TABLE 193 CORNING INCORPORATED: COMPANY OVERVIEW
                        FIGURE 36 CORNING INCORPORATED: COMPANY SNAPSHOT (2022)
             11.1.4 LONZA
                        TABLE 194 LONZA: COMPANY OVERVIEW
                        FIGURE 37 LONZA: COMPANY SNAPSHOT (2022)
             11.1.5 TECAN TRADING AG
                        TABLE 195 TECAN TRADING AG: COMPANY OVERVIEW
                        FIGURE 38 TECAN TRADING AG: COMPANY SNAPSHOT (2022)
             11.1.6 AVANTOR, INC.
                        TABLE 196 AVANTOR, INC.: COMPANY OVERVIEW
                        FIGURE 39 AVANTOR, INC: COMPANY SNAPSHOT (2022)
             11.1.7 REPROCELL INC.
                        TABLE 197 REPROCELL: COMPANY OVERVIEW
             11.1.8 3D BIOTEK LLC
                        TABLE 198 3D BIOTEK LLC: COMPANY OVERVIEW
             11.1.9 EMULATE, INC.
                        TABLE 199 EMULATE, INC.: COMPANY OVERVIEW
             11.1.10 SYNTHECON, INCORPORATED
                        TABLE 200 SYNTHECON, INCORPORATED: COMPANY OVERVIEW
             11.1.11 INSPHERO AG
                        TABLE 201 INSPHERO AG: COMPANY OVERVIEW
             11.1.12 KIRKSTALL LTD.
                        TABLE 202 KIRKSTALL LTD.: COMPANY OVERVIEW
             11.1.13 GREINER BIO-ONE INTERNATIONAL GMBH
                        TABLE 203 GREINER BIO-ONE INTERNATIONAL GMBH: COMPANY OVERVIEW
             11.1.14 PROMOCELL GMBH
                        TABLE 204 PROMOCELL GMBH: COMPANY OVERVIEW
             11.1.15 UPM BIOMEDICALS
                        TABLE 205 UPM: COMPANY OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
     11.2 OTHER PLAYERS 
             11.2.1 CN BIO INNOVATIONS LTD.
             11.2.2 TISSUSE GMBH
             11.2.3 LENA BIOSCIENCES INC.
             11.2.4 CELLENDES GMBH
             11.2.5 ADVANCED BIOMATRIX, INC. (PART OF BICO)
             11.2.6 SYNVIVO INC.
             11.2.7 AMSBIO
             11.2.8 MIMETAS BV
             11.2.9 S-BIO, VAUPELL HOLDINGS INC. (A GROUP COMPANY OF SUMITOMO BAKELITE CO., LTD.)
             11.2.10 NANOFIBER SOLUTIONS
 
12 APPENDIX (Page No. - 238)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the 3D cell culture market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and other approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the 3D cell culture market. The secondary sources referred to for this research study include from government sources, such as the World Health Organization (WHO), American Society for Cell Biology (ASCB), American Society for Gene and Cell Therapy (ASGCT), Centers of Disease Control and Prevention (CDC), and Japan Agency for Medical Research and Development. Secondary sources include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global 3D cell culture market, which was validated through primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

3D Cell Culture Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the 3D cell culture market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the 3D cell culture business of leading players have been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Global 3D cell culture market size: Top-Down Approach

3D Cell Culture Market Size, and Share

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

3D cell culture refers to the cultivation of cells in an environment that closely mimics the three-dimensional structure and conditions found in living tissues or organs. In 3D cell culture, cells are grown within a matrix or scaffold that provides a three-dimensional framework, allowing cells to interact with each other and their environment more realistically. This can include using hydrogels, sponges, scaffolds, or even specialized bioprinting techniques to create a structure that supports cell growth and tissue formation.

Key Stakeholders

  • 3D Cell Culture Product Manufacturers
  • Academic Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Life Science Companies
  • Venture Capitalists and Investors
  • Government Organizations
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Research & Development Companies

Report Objectives

  • To define, describe, and forecast the 3D cell culture market based on product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall 3D cell culture market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East & Africa (MEA)
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments, such as product launches, funding and grants, partnerships, agreements, collaborations, expansions, strategic alliances, and acquisitions in the 3D cell culture market
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Geographic Analysis

  • Further breakdown of the Rest of Europe 3D cell culture market into respective countries
  • Further breakdown of the Rest of Asia Pacific 3D cell culture market into respective countries
  • Further breakdown of the Rest of Latin America 3D cell culture market into respective countries

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Company Information

  • An additional five company profiles
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 4414
Published ON
Jul, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the 3D Cell Culture Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback